Clinical Approval Outlook
by ClinicalIntelPulse in Productivity & SaaS
FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook- Price
- $0.25
- per call in USDC
- Uptime
- 0.0%
- last 30 days
- Response time
- -
- no timed checks yet
- Last check
- Failed
- 24 min ago, next in 37 min
Reliability
Latest check failed 24 min ago: Amount "0.25" is not in atomic token units
Status and outage history · Atom feed · Watch with other listings
How to call it
GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook
Each call costs $0.25 in USDC on Polygon, paid with the request over x402.
Run a free test callOne unpaid request, the way an agent sends it. You see the payment challenge it gets back. Nothing is charged.
Example request
From the listing.
GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29Parameters
| Parameter | Type | Required | Description |
|---|---|---|---|
agency | string | No | |
condition | string | No | |
horizon | string | No | |
lang | string | No |
Example response
The provider's example. We can't check it without paying.
Example response, 38 lines
{
"approval_candidates": [
{
"approval_probability": 85,
"drug": "Lecanemab (Leqembi)",
"ema_status": "CHMP assessment ongoing 2025",
"fda_status": "Full approval received 2023; expanded label applications pending",
"key_risk": "ARIA (amyloid-related imaging abnormalities) safety profile limiting real-world use",
"mechanism": "Anti-amyloid monoclonal antibody (protofibrils)",
"nctId": "NCT03887455",
"sponsor": "Eisai / Biogen",
"trial_result": "Positive — 27% slowing of clinical decline vs placebo (p<0.001)"
}
],
"approval_rate_context": {
"disease_area_historical_phase3_success_pct": 55,
"rare_disease_premium": "Breakthrough therapy designation adds ~15% probability uplift",
"us_approval_rate_phase3_pct": 58
},
"market_context": "Alzheimer's is the highest-value CNS approval category. Any successful amyloid or tau therapy represents $5-15B peak sales potential.",
"pdufa_calendar": [
{
"drug": "Donanemab",
"indication": "Early symptomatic AD",
"pdufa_date": "2025-Q2",
"priority_review": true,
"sponsor": "Eli Lilly"
}
],
"query_summary": {
"agencies": [
"FDA",
"EMA"
],
"condition": "Alzheimer Disease",
"horizon": "18m"
}
}Call it from code
The curl command shows the payment challenge. The JavaScript and Python versions pay and call, and never pay more than $0.25.
curl: see the payment challenge
# bash or zsh: see the payment challenge. Nothing is charged.
curl -sS -g -i 'https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29'
# x402 v2 sends the challenge base64-encoded in the PAYMENT-REQUIRED header (v1 sends it in the body).
# To read the header:
curl -sS -g -o /dev/null -D - 'https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29' \
| grep -i '^payment-required:' | cut -d' ' -f2 | tr -d '\r' | base64 --decodeJavaScript: pay and call
// npm i @x402/fetch @x402/evm viem
import { wrapFetchWithPayment, x402Client } from "@x402/fetch";
import { registerExactEvmScheme } from "@x402/evm/exact/client";
import { privateKeyToAccount } from "viem/accounts";
// Pays at most $0.25 per call.
const client = new x402Client().setSpendControls({ maxAmountPerPayment: "$0.25" });
registerExactEvmScheme(client, { signer: privateKeyToAccount(process.env.EVM_PRIVATE_KEY) });
const pay = wrapFetchWithPayment(fetch, client);
// Not sure it's safe to pay? ToolVet checks it first for $0.005. Pay for that from a separate
// client: this one is capped at $0.25 per payment. GET https://toolvet.app/api/v1/check?url=https%3A%2F%2Fclinicalintelpulse.theaslangroupllc.com%2Fapi%2Fclinical%2Fapproval-outlook
const res = await pay("https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29");
console.log(res.status, await res.text());Python: pay and call
# pip install "x402[requests,evm]"
import os
from eth_account import Account
from x402 import x402ClientSync
from x402.http.clients import x402_requests
from x402.mechanisms.evm import EthAccountSigner
from x402.mechanisms.evm.exact.register import register_exact_evm_client
# Pays at most $0.25 per call.
client = x402ClientSync().set_spend_controls({"max_amount_per_payment": "$0.25"})
register_exact_evm_client(client, EthAccountSigner(Account.from_key(os.environ["EVM_PRIVATE_KEY"])))
with x402_requests(client) as session:
res = session.get("https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook?agency=FDA+%7C+EMA+%7C+both+%28default%3A+both%29&condition=Disease+area+%E2%80%94+e.g.+%22Alzheimer+Disease%22+%7C+%22Multiple+Myeloma%22+%7C+%22NASH%22+%7C+%22Heart+Failure%22+%7C+%22Obesity%22&horizon=12m+%7C+18m+%7C+24m+%28default%3A+18m%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29")
print(res.status_code, res.text)Security scan
No findings
We scan names, descriptions and tool definitions for hidden instructions and other prompt-injection patterns.
Recent checks
| When | Result | HTTP | Time | Price |
|---|---|---|---|---|
| 24 min ago | Amount "0.25" is not in atomic token units | 402 | 219 ms | $0.25 |
| 6 h ago | Amount "0.25" is not in atomic token units | 402 | 188 ms | $0.25 |
| 12 h ago | Amount "0.25" is not in atomic token units | 402 | 227 ms | $0.25 |
| 18 h ago | Amount "0.25" is not in atomic token units | 402 | 188 ms | $0.25 |
| 23 h ago | Amount "0.25" is not in atomic token units | 402 | 223 ms | $0.25 |
Show 6 older checks
| 29 h ago | Amount "0.25" is not in atomic token units | 402 | 189 ms | $0.25 |
| 34 h ago | Amount "0.25" is not in atomic token units | 402 | 212 ms | $0.25 |
| 39 h ago | Amount "0.25" is not in atomic token units | 402 | 229 ms | $0.25 |
| 45 h ago | Amount "0.25" is not in atomic token units | 402 | 172 ms | $0.25 |
| 2 days ago | Amount "0.25" is not in atomic token units | 402 | 241 ms | $0.25 |
| 2 days ago | Amount "0.25" is not in atomic token units | 402 | 153 ms | $0.25 |